Holen Sie sich die Stockscreener-App
45.30
0.82%
0.3461
Schlusskurs vom Vortag:
$44.95
Offen:
$45.06
24-Stunden-Volumen:
17.93M
Relative Volume:
0.94
Marktkapitalisierung:
$67.31B
Einnahmen:
$20.62B
Nettoeinkommen (Verlust:
$3.56B
KGV:
18.99
EPS:
2.3847
Netto-Cashflow:
$3.48B
1W Leistung:
-3.92%
1M Leistung:
-18.96%
6M Leistung:
-52.85%
1J Leistung:
-55.29%
1-Tages-Spanne:
$44.44
$45.48
1-Wochen-Bereich:
$44.44
$47.80
52-Wochen-Spanne:
$44.44
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
45.28 | 66.81B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
87.80 | 154.15B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
310.55 | 115.45B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.87 | 100.32B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
86.66 | 49.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Corp (BSX) Stock Down 4.2% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CAFC Affirms Denial of Preliminary Injunction for Boston Scientific in Spinal Ablation Patent Dispute Against Stryker - IPWatchdog.com
Stryker Fends Off Boston Scientific Bid to Block Ablation Device - Bloomberg Law News
Below Expected Outlook Pressured Boston Scientific (BSX) in Q1 - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific Corp. Stock (US10117L1017): Short interest jumps while analysts stay positive - AD HOC NEWS
Why Did ADBE, CHWY, BSX Slump To 52-Week Lows Last Week? - TradingView
Truist Reiterates Buy Rating for Boston Scientific (BSX) - Insider Monkey
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - mshale.com
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Yahoo Finance
Boston Scientific Stock Price Decline Analysis - Intellectia AI
Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months - The Motley Fool
Boston Scientific shares plunge 53% amid lowered growth forecasts and product challenges - Pluang
UniSuper Management Pty Ltd Has $72.53 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific - Yahoo Finance
Polen Capital Management LLC Sells 1,578,734 Shares of Boston Scientific Corporation $BSX - MarketBeat
Meiji Yasuda America Inc Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Nuveen LLC Lowers Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Great Lakes Advisors LLC Has $169.42 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Analyst recommendations: Adobe, Boston Scientific, Casey's General Stores, Kla Corporation, Zillow Group… - marketscreener.com
Aviva PLC Has $141.66 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Top Boston Scientific (BSX) Competitors 2026 - MarketBeat
Boston Scientific Corp (BSX) Reports Strong Success Rates From Catheter Study - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Scientific stock hits 52-week low at 47.16 USD - Investing.com India
BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock - Insider Monkey
FY2026 EPS Estimate for Boston Scientific Lowered by Analyst - MarketBeat
Nicollet Investment Management Inc. Invests $4.72 Million in Boston Scientific Corporation $BSX - MarketBeat
TD Cowen Cuts Boston Scientific Price Target to $61 Following Watchman Update - HarianBasis.co
Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Stock (BSX) Opinions on Recent Stock Decline - Quiver Quantitative
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MSN
Deutsche Bank AG Cuts Stake in Boston Scientific Corporation $BSX - MarketBeat
Axiom Investors LLC DE Has $156.52 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Why did BSX, LI, ROL stocks fall to 52-week lows on Friday? - MSN
Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential? - Insider Monkey
$BSX StockBoston Scientific Corp | Quick Financials | LAST 12 YEARS Fulham Vs Bournemouth (YHNvQmq85M) - mshale.com
Cerity Partners LLC Purchases 39,345 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Lifted by Fiera Capital Corp - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Clearbridge Investments LLC - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Spinal Cord Simulator Suits Sent to California - news.bloombergtax.com
Boston Scientific to build Indiana distribution center - Yahoo Finance
Boston Scientific Corporation $BSX Shares Sold by ING Groep NV - MarketBeat
Boston Scientific (BSX) Initiates $2B Accelerated Share Repurchase Agreement - Insider Monkey
Boston Scientific Corporation $BSX Shares Sold by Erste Asset Management GmbH - MarketBeat
Egerton Capital UK LLP Purchases 72,580 Shares of Boston Scientific Corporation $BSX - MarketBeat
Capital Research Global Investors Acquires 450,322 Shares of Boston Scientific Corporation $BSX - MarketBeat
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):